Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Defined contribution plan costs

Defined contribution plan costs at other companies

The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
$4.48M+12.6%
HWK
HawkinsHWKN
$778K+68.1%
CBIZ logo
CBIZCBZ
$8.53M+48.9%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.44M-4.5%
HNI logo
HNIHNI
$6.4M-5.2%
ADMA Biologics logo
ADMA BiologicsADMA
$425K+13.3%

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount.

The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's defined contribution plan costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's defined contribution plan costs?
BioCryst Pharmaceuticals (BCRX) reported defined contribution plan costs of $1.44M in Q4 2025.
How has BioCryst Pharmaceuticals's defined contribution plan costs changed year-over-year?
BioCryst Pharmaceuticals's defined contribution plan costs decreased by 4.5% year-over-year, from $1.51M to $1.44M.
What is the long-term trend for BioCryst Pharmaceuticals's defined contribution plan costs?
Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's defined contribution plan costs has grown at a 19.4% compound annual growth rate (CAGR), from $2.83M to $5.76M.
What does defined contribution plan costs mean?
Represents the total employer-funded contributions made to employee retirement savings plans, such as 401(k) matching programs. This metric reflects the company's commitment to employee benefits and serves as a component of total personnel-related compensation expenses.